Nextech Invest
Zurichnextechinvest.com
Overview
Nextech Invest is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland, that invests in emerging biotechnology companies developing transformative cancer medicines and precision oncology therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Flare Therapeutics | Jun 2026 | Series C | Lead |
| Stipple Bio | Apr 2026 | Series A | Lead |
| Atavistik Bio | Mar 2026 | Series B | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
Key People
Jakob Loven
Managing Partner
Kanishka Pothula
Managing Partner
Thilo Schroeder
Managing Partner
Melissa McCracken
Partner
Rocco Sgobbo
Partner
Niresh Berinpanathan
Principal
Sarah Soo-Hoo
Principal
Thomas Geninatti
Principal
Daniel Michaeli
Biotech Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
